Explorative Study of AZD1305 in Atrial Fibrillation Patients

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Explorative study in Atrial Fibrillation patients to assess Safety and Pharmacokinetics at initiation of treatment and at steady state

Phase 2

AstraZeneca